Unihealth Consultancy Ltd

Unihealth Consul Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Unihealth Consultancy Ltd

₹ 130 4.10%
15 May - close price
Company website NSE - SME: UNIHEALTH
About

Incorporated in 2010, Unihealth Consultancy Limited is a healthcare service provider based out of Mumbai and has operational presence across a few countries in the African Continent.[1]

Key Points

Business segments[1] Unihealth Consultancy's business segments include Medical Centres, Hospitals, Consultancy Services, Distribution of Pharmaceutical and medical Consumable Products, and Medical Value Travel.

Website NSE - SM
  • Market Cap ₹ 199 Cr.
  • Current Price ₹ 130
  • High / Low ₹ 166 / 116
  • Stock P/E 149
  • Book Value ₹
  • Dividend Yield 0.00 %
  • ROCE 10.7 %
  • ROE 14.0 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Debtor days have improved from 297 to 118 days.

Cons

  • Company has low interest coverage ratio.
  • Earnings include an other income of Rs.1.79 Cr.
  • Company's cost of borrowing seems high

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Edit Columns
Loading peers table ...

Half Yearly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2023
0.92
1.23
Operating Profit -0.31
OPM % -33.70%
0.96
Interest 0.32
Depreciation 0.04
Profit before tax 0.29
Tax % -72.41%
0.50
EPS in Rs
Raw PDF
Upcoming result date: 23 May 2024

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2021 Mar 2022 Mar 2023
0.63 1.61 1.92
0.74 0.79 1.33
Operating Profit -0.11 0.82 0.59
OPM % -17.46% 50.93% 30.73%
-0.14 0.94 1.79
Interest 0.80 1.19 1.18
Depreciation 0.11 0.09 0.08
Profit before tax -1.16 0.48 1.12
Tax % 0.00% 0.00% -19.64%
-1.16 0.48 1.34
EPS in Rs
Dividend Payout % 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 19%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 179%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: 14%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2022 Mar 2023 Sep 2023
Equity Capital 1.34 1.39 15.40
Reserves 5.17 11.28 46.66
11.60 12.08 6.14
0.42 0.61 7.77
Total Liabilities 18.53 25.36 75.97
1.50 1.42 1.38
CWIP 0.00 0.00 0.00
Investments 6.15 6.34 6.34
10.88 17.60 68.25
Total Assets 18.53 25.36 75.97

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2021 Mar 2022 Mar 2023
-0.84 1.94
0.73 -7.14
0.15 5.09
Net Cash Flow 0.05 -0.11

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2021 Mar 2022 Mar 2023
Debtor Days 476.09 117.86
Inventory Days
Days Payable
Cash Conversion Cycle 476.09 117.86
Working Capital Days 630.25 184.40
ROCE % 10.73%

Shareholding Pattern

Numbers in percentages

Sep 2023Mar 2024
68.80% 68.80%
5.61% 0.00%
3.31% 0.14%
22.27% 31.05%
No. of Shareholders 1,111979

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

No data available.

Credit ratings